NOW LET US – AI RAG SaaS Studio TP.HCM
NOW LET US
Digital Product Studio
Back to news
DEV-TOOLS...1 min read

New pancreatic cancer drug might open the door to much longer survival times

Share
NOW LET US Article – New pancreatic cancer drug might open the door to much longer survival times

A promising new drug called daraxonrasib has shown breakthrough results in treating pancreatic cancer, nearly doubling the median survival time of patients and offering hope for a new class of cancer treatments.

Treating pancreatic tumours may have revealed cancer’s master switch

A promising drug could be the first of an entirely new class of treatments

Scientists are not usually an excitable bunch. So when many thousands of them recently gave a spontaneous standing ovation (with cheering) in the middle of a lecture, it meant something special happened. At a conference in Chicago at the end of May oncologists went wild over the results of a drug called daraxonrasib, which treats pancreatic cancer. The drug almost doubled median survival times from 6.7 months to 13.2 months. This victory over one of the most challenging cancers was an emotional moment for some.

© 2026 Now Let Us. All rights reserved.

Source: Hacker News

Advertisement
Ad slot ready: 5887729102

More in this category

EXPLORE TOPICS

Discover All Categories

Deep dive into the specific technology sectors that matter most to you.